What is MAT for alcohol use disorder?

Medication-assisted treatment (MAT) for alcohol use disorder combines FDA-approved medications with counseling and behavioral therapies to provide a whole-patient approach. MAT addresses the neurobiological component of addiction while therapy addresses psychological and social factors. Evidence consistently shows MAT plus therapy outperforms either alone.

How effective is medication for alcohol use disorder?

FDA-approved medications roughly double the odds of maintaining sobriety compared to placebo at 6-12 months. Naltrexone reduces heavy drinking days by 25-50%. Acamprosate reduces relapse by 15-30%. Combined with behavioral therapy, outcomes improve further. Despite this evidence, fewer than 10% of people with AUD in the US receive any medication treatment.

Is MAT for alcohol the same as MAT for opioids?

The concept is similar, combining medication with therapy, but the specific medications differ. Alcohol MAT uses naltrexone, acamprosate, or disulfiram. Opioid MAT uses methadone, buprenorphine (Suboxone), or naltrexone. Naltrexone is the only medication used for both conditions.

Can a regular doctor prescribe alcohol use disorder medication?

Yes, unlike buprenorphine for opioid use disorder, AUD medications require no special waiver or certification to prescribe. Any licensed prescriber (MD, DO, NP, PA) can prescribe naltrexone, acamprosate, or disulfiram. A significant barrier is that many primary care providers don't routinely screen for AUD or offer medication treatment.

What off-label medications help with alcohol use disorder?

Gabapentin reduces alcohol withdrawal, cravings, and sleep disruption, well-evidenced off-label option. Topiramate reduces drinking days and heavy drinking episodes. Baclofen (used in Europe, less common in US) reduces anxiety-driven drinking. Ondansetron is used for early-onset AUD. These require prescription and physician judgment about appropriate use.

How do I find an alcohol use disorder medication provider?

Options include: your primary care doctor (ask directly about AUD medication), addiction medicine specialists (ASAM.org finder), telehealth services (Workit Health, Cerebral, Bicycle Health), SAMHSA's National Helpline (1-800-662-4357), or findtreatment.gov for local providers.

Do AUD medications interact with each other?

Naltrexone and acamprosate are safe to combine, they have additive benefit in some studies. Disulfiram should generally not be combined with naltrexone (limited evidence, unpredictable interaction). Always disclose all medications to your prescriber.

What is the Sinclair Method and is it MAT?

The Sinclair Method (TSM) is a specific protocol for using naltrexone, taking it before each drinking occasion rather than daily, allowing drinking to continue while the blocked reward gradually extinguishes the habit. It is a form of MAT. A Finnish study found 78% success at 12 months with TSM. It is less commonly prescribed in the US but more available through telehealth and self-directed programs like C Three Foundation.

How long should someone take AUD medication?

Most guidelines recommend a minimum of 12 months. Some patients benefit from longer-term use. There is no dependence or withdrawal from stopping naltrexone or acamprosate. Disulfiram should be tapered and stopped with physician guidance. The decision to stop should be made collaboratively based on relapse risk and stability.

Can AUD medications be used with therapy?

Yes, and this combination is strongly recommended. Medications address the neurobiological component of addiction, therapy addresses psychological patterns, triggers, and social factors. The COMBINE trial showed medication + behavioral therapy outperformed either alone. Common complementary therapies include CBT, motivational interviewing, and 12-step facilitation.

What is SBIRT in alcohol treatment?

SBIRT (Screening, Brief Intervention, Referral to Treatment) is a public health approach where healthcare providers briefly screen for risky alcohol use, provide a short intervention if indicated, and refer to treatment if needed. It's the recommended model for integrating AUD identification and treatment into primary care settings.

Are there any medications being developed for AUD?

Yes, research is active. Sodium oxybate (GHB) is approved in Europe. Nalmefene (Selincro) is approved in the EU as an as-needed reduction medication. GLP-1 agonists (like semaglutide/Ozempic) are being studied and early research suggests they reduce alcohol cravings in some patients. Novel glutamate-targeting compounds and gene-based approaches are in earlier stages.

Can naltrexone help with binge drinking?

Yes, naltrexone is particularly well-studied for binge drinking. It reduces heavy drinking days by 25-50% in clinical trials and is especially effective when taken before anticipated drinking occasions (Sinclair Method approach).

What percentage of people with AUD receive medication treatment?

Fewer than 10% of people with alcohol use disorder in the US receive any FDA-approved medication. Despite strong evidence, medication is significantly underutilized due to stigma, prescriber unfamiliarity, patient reluctance, and lack of insurance coverage. This gap represents one of the largest unmet needs in addiction medicine.

Is medication-assisted treatment for alcohol covered by insurance?

Yes, FDA-approved medications for alcohol use disorder (naltrexone, acamprosate, disulfiram) are generally covered by health insurance under the Mental Health Parity and Addiction Equity Act, which requires insurers to cover substance use disorder treatment at parity with other medical conditions. Medicaid covers MAT for alcohol in all states. Medicare Part D covers oral naltrexone and acamprosate. Coverage specifics vary by plan, check your formulary. The Vivitrol injectable (monthly naltrexone) is also typically covered but may require prior authorization.

Medication & Treatment

Medication-Assisted Treatment for Alcohol: Complete Guide

Q: Which AUD medication is best?

There is no single best medication, choice depends on patient profile. Naltrexone is typically first-line for reward-motivated drinkers who haven't stopped yet and have no opioid dependence. Acamprosate is preferred for physically dependent drinkers who've completed detox, especially those who can't take naltrexone due to opioid use or liver disease. Disulfiram is occasionally used for highly motivated patients who want a deterrent.

Q: Can you take AUD medication without going to rehab?

Yes, all FDA-approved AUD medications can be prescribed in outpatient settings by any licensed prescriber. Primary care doctors, addiction medicine specialists, and telehealth providers can prescribe naltrexone, acamprosate, and disulfiram without requiring inpatient rehab. Telehealth has made medication access significantly easier.

Q: Does insurance cover AUD medication?

Yes, the ACA requires most insurance plans to cover AUD treatment including medications. Generic naltrexone costs $20-50/month, generic acamprosate $50-100/month, and generic disulfiram $20-40/month. Vivitrol (injectable naltrexone) at $1,500+/month typically requires prior authorization but is covered by most commercial plans and Medicaid.

Dr. Ananya Krishnan, PhD Clinical Psychology · Reviewed September 2026

Quick Answer

Three medications are FDA-approved for alcohol use disorder: naltrexone (blocks reward, start without detox), acamprosate/Campral (reduces withdrawal anxiety, needs detox first), and disulfiram/Antabuse (makes you sick if you drink, rarely first-line). MAT doubles sobriety odds vs placebo. Yet fewer than 10% of people with AUD in the US receive any medication, a massive treatment gap.

Alcohol use disorder has three FDA-approved medications with strong evidence, better evidence than most psychiatric medications. Yet it's treated as if willpower and support groups are the only options. If you have AUD and you're not using medication, you're fighting with one hand tied behind your back.

3FDA-approved AUD medications

2×better sobriety odds vs placebo

<10%of AUD patients receive medication

No Rx waiverany doctor can prescribe

The Three FDA-Approved AUD Medications

Naltrexone

First-line · Oral or injectable

Blocks opioid receptors that mediate alcohol's reward. Can be taken while still drinking. 50mg daily or via Sinclair Method (before drinking only). Also available as Vivitrol monthly injection.

Acamprosate (Campral)

First-line · Post-detox only

Stabilizes glutamate/GABA imbalance from chronic alcohol use. Reduces anxiety, restlessness, and discomfort of early sobriety. Requires abstinence to start. 666mg 3× daily.

Disulfiram (Antabuse)

Second-line · Abstinence required

Blocks alcohol metabolism causing severe nausea, flushing, and heart palpitations if you drink. Requires complete abstinence and high motivation. 250–500mg daily.

Vivitrol

First-line · Monthly injection

Extended-release injectable naltrexone (380mg). Same mechanism as oral naltrexone, eliminated daily adherence problem. One shot covers 28–30 days. Better real-world retention.

Choosing the Right Medication

If you..	Consider	Why
Haven't stopped yet, drink for pleasure	Naltrexone / Vivitrol	Blocks reward without requiring abstinence first
Completed detox, drink to escape anxiety	Acamprosate	Reduces PAWS anxiety that drives relapse
Struggle with daily pill adherence	Vivitrol injection	Once-monthly, eliminates adherence issue
Use opioids or need opioid pain meds	Acamprosate	Naltrexone blocks opioid effect
Have liver damage from alcohol	Acamprosate	No hepatotoxicity, naltrexone has liver monitoring requirements
Highly motivated, want a strong deterrent	Disulfiram	Makes drinking physically miserable
Severe AUD, highest relapse risk	Naltrexone + Acamprosate	Additive benefit in some trials, different mechanisms

Off-Label Medications with Evidence

Gabapentin (Neurontin): Reduces alcohol withdrawal, cravings, and sleep disruption. Widely used off-label, well-evidenced. Effective for anxiety-driven drinking and PAWS.
Topiramate (Topamax): Reduces heavy drinking days and overall consumption. More side effects than naltrexone (cognitive blunting) but effective. Off-label.
Baclofen: GABA-B agonist approved in France for AUD. Some evidence for anxiety-driven drinking. Less commonly used in the US.
Ondansetron: 5-HT3 antagonist effective for early-onset AUD (before age 25). Less evidence for late-onset.

How to Access MAT for Alcohol

Primary care doctor: Ask directly. "I have alcohol use disorder and would like to discuss medication." Any licensed prescriber can prescribe all three FDA-approved AUD medications without special certification.
Addiction medicine specialist: Most experienced option. Use ASAM.org to find one near you.
Telehealth: Workit Health, Cerebral, and Bicycle Health offer AUD medication consultations via video within 24–72 hours. Often cheaper and more accessible than in-person.
SAMHSA helpline: 1-800-662-4357, free, confidential referral to local treatment providers.
Hospital or ER: If you're in active withdrawal, the ER is appropriate, and can initiate medication before discharge with referral to outpatient follow-up.

MAT + Therapy: The Winning Combination

The COMBINE trial, the largest US study of AUD treatment, confirmed what smaller trials had suggested: medication combined with behavioral therapy outperforms either alone. Common effective therapies alongside MAT include cognitive behavioral therapy (CBT), motivational interviewing (MI), contingency management, and 12-step facilitation.

Medication addresses why alcohol feels necessary neurologically. Therapy addresses the patterns, triggers, and beliefs that built the habit. Both are necessary for most people.

Frequently Asked Questions

What medications are approved for alcohol use disorder?

Naltrexone (oral and injectable/Vivitrol), acamprosate (Campral), and disulfiram (Antabuse) are the three FDA-approved medications. Several are used off-label including gabapentin and topiramate.

Which AUD medication is best?

Depends on patient profile. Naltrexone is typically first-line for reward-motivated drinkers who haven't stopped. Acamprosate is preferred for physically dependent drinkers post-detox managing PAWS. Vivitrol is better when daily adherence is a concern.

Can you take AUD medication without going to rehab?

Yes. All FDA-approved AUD medications can be prescribed in outpatient settings by any licensed prescriber. Telehealth has made this especially accessible.

How effective is MAT for alcohol?

FDA-approved medications roughly double the odds of maintaining sobriety vs placebo at 6–12 months. Naltrexone reduces heavy drinking days by 25–50%. Combined with therapy, outcomes improve further.

Does insurance cover AUD medication?

Yes, ACA requires most plans to cover AUD treatment. Generic naltrexone is $20–50/month, generic acamprosate $50–100/month. Vivitrol requires prior auth but is covered by most plans.

Can a regular doctor prescribe AUD medication?

Yes, unlike buprenorphine (opioids), AUD medications require no special waiver. Any MD, DO, NP, or PA can prescribe them.

Is Antabuse still used?

Yes but rarely as first-line. It makes you severely sick if you drink, requiring complete abstinence and strong motivation. Most guidelines prefer naltrexone or acamprosate now.

What percentage of AUD patients get medication?

Fewer than 10% in the US, despite strong evidence. This is one of the largest treatment gaps in addiction medicine, driven by stigma, prescriber unfamiliarity, and patient reluctance.

What is medication-assisted treatment for alcohol?

Medication-assisted treatment (MAT) for alcohol: MAT refers to the use of FDA-approved medications, combined with counseling and behavioral support, to treat alcohol use disorder. For alcohol specifically, three medications are FDA-approved: naltrexone (oral daily or extended-release injectable Vivitrol), blocks opioid receptors, reducing alcohol's rewarding effects, acamprosate (Campral), normalizes the glutamate/GABA imbalance of protracted withdrawal, reducing the discomfort of abstinence, disulfiram (Antabuse), causes aversive physical reactions when alcohol is consumed, deterring drinking through negative reinforcement. MAT is evidence-based: medications significantly improve abstinence rates, reduce heavy drinking, and improve quality of life compared to behavioral treatment alone. MAT is underutilized: fewer than 10% of people with alcohol use disorder receive pharmacotherapy despite strong evidence of benefit.

Is medication the best treatment for alcohol use disorder?

Effectiveness of medication for AUD: combination of medication + behavioral treatment is the most effective approach for alcohol use disorder. Medications alone vs. behavioral treatment alone: both produce meaningful improvement, their effects are additive. Comparative data: naltrexone + behavioral therapy vs. behavioral therapy alone, naltrexone consistently improves outcomes. The COMBINE study: the largest US trial of AUD treatment, naltrexone and behavioral therapy each independently improved outcomes, the combination was most effective for many outcomes. Long-term success: medication adherence is the critical variable, medication that isn't taken doesn't help. Monthly injectable naltrexone (Vivitrol) addresses adherence by eliminating the daily decision. Individual tailoring: different patients respond to different medications, naltrexone for reward-driven drinking, acamprosate for abstinence-discomfort, disulfiram for commitment-focused patients with strong social support.

What are the three FDA-approved medications for alcohol use disorder?

FDA-approved AUD medications: naltrexone: mu-opioid receptor antagonist, blocks alcohol's rewarding effects through the endogenous opioid system. Available as once-daily oral tablet or monthly injection (Vivitrol). Most evidence for reducing heavy drinking. Does not require abstinence before starting (for non-physically-dependent patients). Acamprosate (Campral): GABA/glutamate modulator, reduces the neurological discomfort of abstinence (protracted withdrawal syndrome). Taken three times daily. Requires abstinence before starting. Better suited for patients whose primary challenge is making abstinence comfortable. Disulfiram (Antabuse): blocks aldehyde dehydrogenase enzyme in alcohol metabolism, causing acetaldehyde accumulation, flushing, nausea, vomiting, and cardiovascular effects when alcohol is consumed. Works through deterrence. Requires strong motivation and ideally observed administration. Most effective when supervised.

Who should consider medication for alcohol use disorder?

Candidates for AUD pharmacotherapy: anyone with moderate-severe alcohol use disorder (meeting 4+ of the 11 DSM-5 criteria) is a reasonable candidate. Particularly appropriate for: people who have tried to reduce or stop drinking and found it difficult without support, people with high craving intensity, people with multiple prior relapse episodes, people with a family history of alcoholism (which predicts stronger neurobiological response to naltrexone), people with co-occurring mental health conditions (medication helps stabilize the neurochemical component). Barriers to medication use that should be challenged: 'I should be able to do this on my own', addiction is a brain disease with documented neurochemical components, medication is as appropriate as using medication for hypertension or diabetes. Many people benefit from medication even if they also attend AA or therapy. They are complementary, not alternatives.

Can I get MAT for alcohol from my primary care doctor?

Primary care prescribing of AUD medications: yes. All three FDA-approved AUD medications (naltrexone, acamprosate, disulfiram) can be prescribed by primary care physicians. Unlike buprenorphine (Suboxone) for opioid use disorder, AUD medications do not require a special DEA waiver. Barriers in practice: most primary care physicians have limited training in addiction medicine and may not routinely screen for or treat AUD with medication. What to say: 'I have alcohol use disorder and I'd like to discuss naltrexone or acamprosate.' This directness allows the appointment to be productive. If primary care is unable to help: addiction medicine specialists, psychiatrists, and addiction-focused telemedicine platforms (Ria Health, ARISE, Boulder Care, Workit Health) are accessible alternatives. SAMHSA treatment locator (findtreatment.gov) lists local AUD treatment providers. Telemedicine has dramatically expanded access to AUD pharmacotherapy, a prescription can be obtained through a virtual visit.

What is the difference between MAT and willpower-based recovery?

MAT vs. willpower-based recovery for alcohol: the framing matters. Alcohol use disorder involves documented neurobiological changes, dopamine system dysregulation, glutamate/GABA imbalance, altered opioid receptor function. That make quitting by willpower alone much harder than for someone without these changes. Willpower-based recovery (12-step, behavioral therapy alone): works for many people, particularly those with milder AUD and strong behavioral/social support. Not a moral failing when it doesn't work, the neurobiological load varies. MAT: adds pharmacological support for the neurobiological component. It doesn't replace motivation, community, or behavioral work. It reduces the neurological friction, making the same amount of motivation more effective. The evidence: people who use both MAT and behavioral treatment have substantially better outcomes than those using either alone. False dichotomy: framing MAT vs. '12-step' as opposed is inaccurate, AA literature supports use of appropriate medication. Many AA members take naltrexone.

How long does medication-assisted treatment last?

Duration of MAT for alcohol: guidelines do not specify a single treatment duration, individual factors determine length. Standard recommendation: at least 12 months based on trial evidence. Most AUD medications produce ongoing benefit throughout the treatment period. Higher-risk patients (severe AUD, limited social support, multiple prior relapses): may benefit from 24+ months of treatment. Stopping medication: AUD medications do not produce physical dependence and can be discontinued at any time without withdrawal. However: stopping medication increases relapse risk. Discontinuation should be a collaborative decision made after a period of stable sobriety, with established behavioral coping, and with awareness of the increased risk period immediately after stopping. Some patients choose to take medication indefinitely, for a chronic relapsing condition, long-term pharmacotherapy is a reasonable choice, similar to long-term medication for other chronic conditions.

Does insurance cover MAT for alcohol?

Insurance coverage for AUD medications: federal parity law (the Mental Health Parity and Addiction Equity Act) requires that insurance plans cover addiction treatment at parity with other medical conditions. Coverage in practice: most commercial insurance plans cover FDA-approved AUD medications (naltrexone, acamprosate, disulfiram) with prior authorization. Medicare Part D covers all three FDA-approved AUD medications. Medicaid: coverage varies by state, most state Medicaid programs cover at least naltrexone. Cost without insurance: generic naltrexone is very affordable (often under $30/month with GoodRx), generic acamprosate is moderately priced, Vivitrol (injectable naltrexone) is expensive but manufacturer assistance programs exist. Appealing denials: if coverage is denied, the prescribing provider can submit a letter of medical necessity. SAMHSA (1-800-662-4357) can help navigate access and payment issues.

Can I drink while on disulfiram?

Drinking on disulfiram (Antabuse): drinking while taking disulfiram produces the disulfiram-alcohol reaction, a severe, unpleasant, and potentially medically serious response. Mechanism: disulfiram blocks aldehyde dehydrogenase, the enzyme that metabolizes acetaldehyde (the first breakdown product of alcohol). Acetaldehyde accumulates to toxic levels within 10-30 minutes of drinking. Symptoms: facial flushing, intense throbbing headache, nausea and vomiting, palpitations, shortness of breath, sweating, hypotension, and profound discomfort. Severity varies by amount consumed. Severe reactions can include chest pain, arrhythmias, and rarely, cardiovascular collapse. Duration: symptoms typically last 30-60 minutes per standard drink. The deterrent value: knowing that any alcohol will cause this reaction deters drinking. However, the deterrence only works if disulfiram is being taken consistently, supervised administration (by a family member or clinic) significantly improves adherence and efficacy.

Are there new medications being developed for alcohol use disorder?

New AUD medications in development: gabapentin: increasingly used off-label for AUD, reduces withdrawal symptoms, craving, and may improve sleep in early recovery. Not FDA-approved for AUD specifically, but widely prescribed. Stronger evidence needed. Topiramate: anticonvulsant with evidence from multiple RCTs for reducing heavy drinking, not FDA-approved for AUD but sometimes prescribed off-label. GLP-1 agonists (semaglutide, liraglutide, Ozempic/Wegovy class): early but promising data suggesting GLP-1 receptor activation reduces alcohol craving and consumption, the same pathway that reduces food craving. Clinical trials underway. Sodium oxybate (GHB): approved in Italy and Austria for AUD, evidence is strong, regulatory issues have limited US approval. Psilocybin: early-phase trials showing promising results for AUD and other substance use disorders, psychedelic-assisted therapy protocols are in active research. Ibudilast: a phosphodiesterase inhibitor with early evidence for reducing heavy drinking days in AUD, Phase 2 trials ongoing.

What behavioral treatments are combined with MAT for alcohol?

Behavioral treatments paired with AUD medication: MAT medications plus behavioral treatment consistently outperform either alone. Key behavioral approaches: CBT (Cognitive Behavioral Therapy): identifies triggers, irrational beliefs, and coping deficits, builds skills to manage high-risk situations, works directly with the psychological component of AUD. Motivational Interviewing (MI): resolves ambivalence about change, builds intrinsic motivation, used in single sessions or as an ongoing approach. 12-Step Facilitation: structured engagement with AA, peer support, accountability, and community. SMART Recovery: secular, CBT-based peer support groups, good for patients who prefer non-spiritual frameworks. Contingency Management: reward systems for sustained abstinence, most evidence in stimulant use disorders but applicable to AUD. Couples and family therapy: addresses the relational component of AUD. Format options: individual therapy, group therapy, intensive outpatient programs (IOP), residential treatment, partial hospitalization programs (PHP). Higher intensity treatment is appropriate for more severe AUD or after multiple outpatient relapses.

How do I start MAT for alcohol use disorder?

Starting MAT for alcohol: step 1: medical assessment, a healthcare provider evaluates severity of AUD, drinking history, withdrawal risk, liver function, kidney function (for acamprosate), and opioid use (for naltrexone). Step 2: detox if needed, patients with physical dependence need medically supervised detox before starting acamprosate or naltrexone. Naltrexone can sometimes be started during or immediately after detox, acamprosate starts once abstinence is achieved. Disulfiram requires 24-48 hours of abstinence before the first dose. Step 3: medication selection, based on the patient's drinking pattern, motivation for abstinence vs. reduction, liver function, and other factors. Step 4: initiation and monitoring, liver function monitoring, side effect assessment, and outcome tracking. Step 5: integrate behavioral support, medication is most effective combined with counseling. Finding a provider: your primary care physician, an addiction medicine specialist, or a telemedicine addiction service (Ria Health, Boulder Care, ARISE, Workit Health).

Support your medication treatment with Forge

Track sobriety streaks, log cravings, and monitor your progress, whether you're on naltrexone, Vivitrol, Campral, or any other treatment.

Download Forge free →